Replies to post #181 on Study of Signals (SoS)

[j.c.]

That doji above the upper bb, a couple days ago, seems to be a very good sell indicator. Would be good if it can stay above $10. but I wouldn't count on it unless something fundamentally changes. Lower bb is down around 9.35 (which is still higher than the analyst price target of 9 - note below - don't know if it's changed since then). My guess is sideways to lower.



Had to go look at what caused the sell off...
Last June, Neurocrine (nasdaq: NBIX - news - people ) said Pfizer (nyse: PFE - news - people ) terminated their partnership for indiplon
decision to lay off its 200-person sales force is a disappointment
Samimy maintained a price target of $9 on Neurocrine and said indiplon could receive FDA approval in 2008
http://www.forbes.com/2006/07/27/neurocrine-0727markets16.html?partner=yahootix